Rallybio
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants Hematologic Diseases, Autoimmune Diseases | Phase 1 | 2025-04-14 |
| Terminated | Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloim Fetal and Neonatal Alloimmune Thrombocytopenia | Phase 2 | 2024-11-21 |
| Completed | Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal All Fetal and Neonatal Alloimmune Thrombocytopenia | — | 2022-03-14 |